Ozureprubart
N/A
Report date: 2026/05/17 20:00:15
Base Information
Drug NameOzureprubart
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJiangsu Jiye Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesRapt Therapeutics IncJiangsu Jiye Biopharmaceutical Co LtdJiangxi Jemincare Group Co Ltd
Inactive CompaniesN/A
Active Indications +[9]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A